The fraction of activated FAK and Src was increased by, respectively, 80% and 58% in AD vs. control brains (Fig. 2b), in good agreement with the 67% increase in KCNB1 oxidation/oligomerization. This evidence concerns the gene KCNB1 and Alzheimer disease.